The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
J Nucl Med
.
2020 Dec;61(Suppl 2):263S-272S.
doi: 10.2967/jnumed.120.254532.
Authors
Wolfgang A Weber
1
,
Johannes Czernin
2
,
Carolyn J Anderson
3
,
Ramsey D Badawi
4
,
Henryk Barthel
5
,
Frank Bengel
6
,
Lisa Bodei
7
,
Irène Buvat
8
,
Marcelo DiCarli
9
,
Michael M Graham
10
,
Jan Grimm
7
11
,
Ken Herrmann
12
,
Lale Kostakoglu
13
,
Jason S Lewis
7
11
,
David A Mankoff
14
,
Todd E Peterson
15
,
Heinrich Schelbert
2
,
Heiko Schöder
7
,
Barry A Siegel
16
,
H William Strauss
7
Affiliations
1
Technical University Munich, Munich, Germany w.weber@tum.de.
2
UCLA, Los Angeles, California.
3
University of Missouri, Columbia, Missouri.
4
University of California, Davis, California.
5
University of Leipzig, Leipzig, Germany.
6
Medizinische Hochschule Hannover, Hannover, Germany.
7
Memorial Sloan Kettering Cancer Center, New York, New York.
8
Institut Curie, Université PSL, Inserm, Orsay, France.
9
Harvard Medical School, Boston, Massachusetts.
10
University of Iowa, Iowa City, Iowa.
11
Weill Cornell Medical College, New York, New York.
12
University Hospital Essen, Essen, Germany.
13
University of Virginia, Charlottesville, Virginia.
14
University of Pennsylvania, Philadelphia, Pennsylvania.
15
Vanderbilt University Medical Center, Nashville, Tennessee; and.
16
Washington University, Saint Louis, Missouri.
PMID:
33293447
DOI:
10.2967/jnumed.120.254532
No abstract available
Publication types
Review
MeSH terms
Humans
Molecular Imaging*
Nuclear Medicine*
Therapeutics*